A role of estrogen/ERalpha signaling in BRCA1-associated tissue-specific tumor formation.

作者: W Li , C Xiao , B K Vonderhaar , C-X Deng

DOI: 10.1038/SJ.ONC.1210527

关键词:

摘要: Estrogen and its receptor alpha (ERalpha) have been implicated in the tissue-specific tumorigenesis associated with BRCA1 mutations. However, majority of breast cancers developed human mutation carriers are ERalpha-negative, challenging link between estrogen/ERalpha cancer formation. Using a mouse model lacking full-length form BRCA1, here we show that ERalpha is highly expressed premalignant mammary gland initiation stages tumorigenesis, although expression gradually diminished during tumor progression. We demonstrate absence increases sensitivity cells to estrogen-induced extracellular signal-regulated kinase 1/2 phosphorylation cyclin D1 expression. The turns proliferation ERalpha-positive from paracrine fashion an autocrine or endocrine fashion. Consequently, BRCA1-mutant sensitized cell vitro vivo. These findings illustrate molecular mechanism for signals BRCA1-associated formation, identify several key elements estrogen/ERalpha-signaling cascade can serve as potential therapeutic targets tumorigenesis.

参考文章(35)
Chu-Xia Deng, Xiaoling Xu, Generation and analysis of Brca1 conditional knockout mice. Methods of Molecular Biology. ,vol. 280, pp. 185- 200 ,(2004) , 10.1385/1-59259-788-2:185
Amy M. Trauernicht, Thomas G. Boyer, BRCA1 and Estrogen Signaling in Breast Cancer Breast disease. ,vol. 18, pp. 11- 20 ,(2003) , 10.3233/BD-2003-18103
Korach Ks, Couse Jf, Migliaccio S, Lubahn Db, Washburn Tf, Eddy Em, Curtis Sw, Schomberg Dw, Snedeker Sm, Lindzey J, Kimbro Ks, Smith Ep, Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Progress in Hormone Research. ,vol. 51, pp. 159- ,(1996)
Xiaoling Xu, Wenhui Qiao, Steven P. Linke, Liu Cao, Wen-Mei Li, Priscilla A. Furth, Curtis C. Harris, Chu-Xia Deng, Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis Nature Genetics. ,vol. 28, pp. 266- 271 ,(2001) , 10.1038/90108
A. Migliaccio, M. Di Domenico, G. Castoria, A. de Falco, P. Bontempo, E. Nola, F. Auricchio, Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. The EMBO Journal. ,vol. 15, pp. 1292- 1300 ,(1996) , 10.1002/J.1460-2075.1996.TB00471.X
Richard J Santen, Robert Xinde Song, Robert McPherson, Rakesh Kumar, Liana Adam, Meei-Huey Jeng, Wei Yue, The role of mitogen-activated protein (MAP) kinase in breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. ,vol. 80, pp. 239- 256 ,(2002) , 10.1016/S0960-0760(01)00189-3
Steven G Brodie, Xiaoling Xu, Wenhui Qiao, Wen-Mei Li, Liu Cao, Chu-Xia Deng, Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice. Oncogene. ,vol. 20, pp. 7514- 7523 ,(2001) , 10.1038/SJ.ONC.1204929